The MarketWatch News Department was not involved in the creation of this content.-- Dr. Lovly brings nearly two decades of experience in clinical care, research and academic leade ...
Dr. Christine Lovly, Division Chief of Thoracic Medical Oncology at City of Hope, discusses the increase in lung cancer among ...
“Doctors have historically treated advanced non-small cell lung cancer with immune checkpoint inhibitors, sometimes combined with chemotherapy,” explained Dr. Nath, City of Hope assistant professor ...
Since arriving in Orange County, City of Hope has served more than 40,000 patients and is expected to create over 1,700 local ...
Lung cancer remains the leading cause of cancer death in the U.S., responsible for about 1 in 4, but major advances in ...
Dr. Lovly brings nearly two decades of experience in clinical care, research and academic leadership to her new role. Her work has advanced personalized therapies that improve outcomes and quality of ...
LOS ANGELES — City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center named a Top 5 “Best Hospital” in ...
LOS ANGELES--(BUSINESS WIRE)--City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the ...